Market Research Logo

Global Acute Ischemic Stroke Therapeutics Market 2017-2021

Global Acute Ischemic Stroke Therapeutics Market 2017-2021

About Acute Ischemic Stroke Therapeutics

AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.

Technavio’s analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global acute ischemic stroke therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs from various drug classes.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Acute Ischemic Stroke Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bayer
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • Sanofi
Other prominent vendors
  • Biogen
  • Daiichi Sankyo
  • Pfizer
Market driver
  • Increasing adoption of NOACs
  • For a full, detailed list, view our report
Market challenge
  • Unmet needs for anticoagulant reversal agents
  • For a full, detailed list, view our report
Market trend
  • TBI, a value-addition in AIS research
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
  • Acute ischemic stroke (AIS): An overview
    • Ischemia
    • IHD
    • Stroke
    • AIS
      • Table Symptoms of AIS
  • Market landscape
    • Market overview
      • Table Global AIS therapeutics market: Snapshot
    • Market size and forecast
      • Table Global AIS therapeutics market 2016-2021 ($ millions)
      • Table Mechanism of action of alteplase
      • Table Global AIS therapeutics market: Opportunity analysis
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline snapshot
    • Table Key clinical trials
  • Market segmentation by drug-class
    • Table Global AIS therapeutics market segmentation by drug-class
    • Table Global AIS therapeutics market share by drug-class 2016
    • Thrombolytic therapeutics
      • Table Global AIS thrombolytic therapeutics market 2016-2021 ($ millions)
    • Antihypertensive therapeutics
      • Table Global AIS antihypertensive therapeutics market 2016-2021 ($ millions)
    • Antiplatelet therapeutics
      • Table Global AIS antiplatelet therapeutics market 2016-2021 ($ millions)
    • Anticoagulants
      • Table Global AIS anticoagulant therapeutics market 2016-2021 ($ millions)
    • Others
  • Geographical segmentation
    • Market overview based on geography
      • Table Global AIS therapeutics market share by geography 2016 and 2021
      • Table Global AIS therapeutics market by geography 2016-2021 ($ millions)
      • Table Global AIS therapeutics market by geography 2016-2021 (% share)
      • Table AIS therapeutics market scenario in different geographies
    • AIS therapeutics market in Americas
      • Table Market scenario in Americas
      • Table Stroke scenario in US: An overview
      • Table AIS therapeutics market in Americas 2016-2021 ($ millions)
    • AIS therapeutics market in EMEA
      • Table Market scenario in EMEA
      • Table AIS therapeutics market in EMEA 2016-2021 ($ millions)
    • AIS therapeutics market in APAC
      • Table Market scenario in APAC
      • Table AIS therapeutics market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Prevalence of stroke in US
      • Table ACTIVASE regional sales 2015 and 2016
      • Table Prevalence of obesity among US adults in 2015
    • Market challenges
  • Market trends
    • TBI, a value-addition in AIS research
    • Advent of genomic medicine
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global AIS therapeutics market 2016
    • Key news
  • Key vendor analysis
    • Bayer
      • Table Bayer: Key highlights
      • Table Bayer: Strength assessment
      • Table Bayer: Strategy assessment
      • Table Bayer: Opportunity assessment
    • Boehringer Ingelheim
      • Table Boehringer Ingelheim: Key highlights
      • Table Boehringer Ingelheim: Strength assessment
      • Table Boehringer Ingelheim: Strategy assessment
      • Table Boehringer Ingelheim: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report